Nutritional Status and Body Composition of Adult Patients With Crohn's Disease
A Multi-center, Cross-sectional Observational Study on Nutritional Status and Body Composition of Adult Patients With Crohn's Disease
1 other identifier
observational
100
1 country
1
Brief Summary
Patients with Crohn's disease generally have nutritional risks and malnutrition. The investigators will conduct a multicenter cross-sectional study to discover nutritional status and body composition of Chinese adult patients with CD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2021
CompletedFirst Posted
Study publicly available on registry
June 7, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedJuly 15, 2021
April 1, 2021
1.8 years
April 11, 2021
July 14, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Appendicular skeletal mass index
Bioelectrical impedance analysis
Within 48 hours of admission to hospital
Secondary Outcomes (4)
Body composition
Within 48 hours of admission to hospital
Nutritional risk screening
Within 48 hours of admission to hospital
Nutritional assessment
Within 48 hours of admission to hospital
Grip strength
Within 48 hours of admission to hospital
Study Arms (1)
adult patients with Crohn's disease
multi-center cross-sectional study
Interventions
Eligibility Criteria
Chinese adult patients with Crohn's Disease
You may qualify if:
- Age ≥ 18 years old;
- diagnosis of CD;
- Admission time \<48 hours;
- Subject has voluntarily signed and dated an informed consent form.
You may not qualify if:
- Emergency surgery for intestinal fistula or abdominal abscess;
- Unstable vital signs or unstable hemodynamics;
- Pregnant or lactating women;
- Admission to hospital due to other critical illnesses (such as tumor, HIV, severe infections requiring ventilator or CRRT treatment);
- Dying patients whose life expectancy does not exceed 24 hours;
- Severe liver insufficiency (liver function score 11-15 or total bilirubin\> 3mg/dL or tissue biopsy diagnosed as liver cirrhosis, hepatic encephalopathy, portal hypertension with history of gastrointestinal hemorrhage, etc.);
- Severe renal insufficiency (creatinine value is 2 times higher than the upper limit of normal);
- Severe metabolic diseases (such as metabolic syndrome, hyperthyroidism, etc.);
- Patients whose burn area exceeds 20% of the body surface area;
- Immunodeficiency, autoimmune disease, or receiving immunosuppressive treatment for diseases other than CD (such as organ transplantation, etc.);
- Those who are not suitable for body composition analysis
- Patients who have been selected for other clinical studies or have been selected for this study;
- Subjects are unwilling to participate in this study or refuse to sign informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310009, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2021
First Posted
June 7, 2021
Study Start
July 1, 2021
Primary Completion
May 1, 2023
Study Completion
May 1, 2023
Last Updated
July 15, 2021
Record last verified: 2021-04